Table.
Clinical and AI Evaluation of Patient Cohort
Clinical Evaluation | AI Evaluation | |||
---|---|---|---|---|
AC SUN (Cells) | AC SUN (Flare) | Particles (ptl) | Particle Density (ptl/pxl · 106) | Mean Particle Size (pxl) |
0 | 1+ | 0 | 0 | NA |
0 | 1+ | 2 | 4.4 | 4.8 |
0 | 0 | 1 | 2 | 5 |
0 | 0 | 3 | 5.2 | 3.2 |
0 | 0 | 2 | 5.6 | 3.2 |
0 | 0 | 4 | 9.8 | 3.6 |
0 | 0 | 1 | 2.4 | 3 |
0 | 0 | 7 | 15.7 | 3.3 |
0 | 1+ | 10 | 22.9 | 3.8 |
0 | 0 | 1 | 2.6 | 5 |
0 | 1+ | 3 | 4.9 | 3 |
0 | 0 | 0 | 0 | NA |
0 | 0 | 1 | 2.5 | 4 |
0 | 0 | 4 | 13.8 | 1.9 |
0 | 1+ | 0 | 0 | NA |
0 | 0 | 2 | 4 | 3 |
0 | NA | 2 | 5.6 | 3.8 |
0 | NA | 1 | 3.1 | 7 |
0 | NA | 1 | 3.5 | 2 |
0 | NA | 0 | 0 | NA |
0 | NA | 3 | 4.3 | 4.3 |
0 | NA | 2 | 6.1 | 4.8 |
0 | NA | 0 | 0 | NA |
0 | NA | 0 | 0 | NA |
0 | NA | 0 | 0 | NA |
0 | NA | 0 | 0 | NA |
1.92 ± 0.46 | 4.55 ± 1.09 | 3.82 ± 0.29 | ||
0.5+ | 1+ | 0 | 0 | Na |
0.5+ | 0 | 6 | 14.4 | 3.7 |
0.5+ | 1+ | 2 | 6 | 3.2 |
0.5+ | 2+ | 1 | 2.1 | 3 |
0.5+ | 2+ | 6 | 12.4 | 4.3 |
0.5+ | 1+ | 9 | 16.7 | 2.6 |
4.00 ± 1.44 | 8.60 ± 2.81 | 3.36 ± 0.29 | ||
1+ | NA | 35 | 88.4 | 3.9 |
1+ | 0 | 9 | 15.7 | 3.6 |
1+ | 2+ | 29 | 59.5 | 3.9 |
24.33 ± 7.86 | 54.53 ± 21.13 | 3.80 ± 0.10 | ||
2+ | NA | 7 | 15.4 | 3.2 |
2+ | NA | 31 | 66.2 | 3.5 |
2+ | 1+ | 16 | 43.4 | 5.1 |
2+ | NA | 37 | 56.4 | 4.1 |
22.75 ± 6.86 | 45.35 ± 11.02 | 3.98 ± 0.42 | ||
3+ | 1+ | 152 | 358.5 | 4.1 |
3+ | NA | 81 | 187.1 | 4.4 |
3+ | NA | 119 | 309.1 | 4.2 |
117.33 ± 20.51 | 284.90 ± 50.94 | 4.23 ± 0.09 |
Clinical SUN (cells, flare) and AI (number of particles, particle density (ptl/pxl · -6, mean particle size) evaluation of patient cohort consisting of 32 eyes of 19 patients.
The italic rows signify the control eyes.
NA, not applicable.